A two-year-old company developing molecular “logic” for cancer treatment has been snapped up for $175 million by Gilead Sciences amid a surge of interest in ways to battle disease using engineered immune cells.

Source: Genetic Programmers Are the Next Startup Millionaires – MIT Technology Review

Comments are closed.